marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Maravai LifeSciences Holdings Financial Ratios 2011-2024 | MRVI
Annual Financial Ratios Maravai LifeSciences Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-8.5 | 8.8 | 18.2 | 4.1 | - | - | - | - | - | - | - | - | - |
P/S |
3.5 | 2.2 | 4.2 | 1.3 | - | - | - | - | - | - | - | - | - |
EPS |
-0.9 | 1.7 | 1.6 | 7.4 | -0.0 | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
1.14 B | 2.68 B | 4.14 B | 1.24 B | 433 M | 392 M | - | - | - | - | - | - | - |
EBITDA per Share |
-0.14 | 4.42 | 4.89 | 12.1 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
7.2 | 60.4 | - | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.0 | - | - | - | - | - | - | - | - | - | ||
P/B |
1.3 | 2.1 | 6.1 | 2.3 | - | - | - | - | - | - | - | - | - |
P/CF |
8.0 | 3.6 | 9.0 | 2.4 | - | - | - | - | - | - | - | - | - |
ROE % |
-28.56 | 40.39 | 33.38 | 57.50 | - | - | - | - | - | - | - | - | - |
ROA % |
-8.00 | 9.65 | 9.49 | 7.00 | - | - | - | - | - | - | - | - | - |
ROCE % |
-7.59 | 105.32 | 101.70 | 77.48 | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.1 | 1.7 | 1.4 | 1.1 | - | - | - | - | - | - | - | - | - |
DSO |
122.0 | 52.9 | 26.8 | - | - | - | - | - | - | - | - | - | - |
DIO |
116.0 | 102.3 | 66.9 | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
238.1 | 155.2 | 93.8 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
238.1 | 155.2 | 93.8 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Maravai LifeSciences Holdings
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.7 | -0.05 | -0.09 | -0.05 | -0.05 | - | - | 0.34 | 0.54 | 0.51 | - | 0.46 | 0.44 | 0.24 | - | 0.12 | - | 0.09 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.16 | -0.03 | -0.11 | -0.09 | -0.07 | 0.04 | - | 0.9 | 1.39 | 1.29 | - | 1.35 | 1.4 | 0.96 | - | 0.19 | 0.04 | 0.14 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-34.10 | -6.13 | -4.40 | 3.82 | 9.83 | 19.77 | 24.71 | 42.64 | 55.29 | 71.39 | 63.76 | 76.67 | 102.74 | 79.04 | 84.95 | 72.04 | 28.03 | 26.42 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-9.39 | -1.93 | -1.41 | -0.58 | -0.29 | 3.27 | 6.54 | 9.41 | 9.00 | 12.07 | 7.64 | 8.54 | 8.74 | 5.79 | 5.92 | 5.02 | 1.95 | 1.84 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-57.50 | -9.79 | -7.33 | 11.15 | 26.77 | 51.41 | 62.82 | 114.66 | 152.60 | 208.79 | 212.35 | 264.01 | 263.83 | 193.46 | 100.16 | 100.16 | 48.51 | 39.34 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.9 | 2.2 | 2.2 | 1.6 | 1.7 | 1.6 | 1.7 | - | - | 1.5 | 1.4 | 1.3 | 1.3 | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
47.2 | 46.8 | 58.5 | 64.6 | 69.7 | 112.5 | - | - | 22.6 | 44.4 | - | 33.3 | 43.0 | 53.2 | - | 53.0 | 99.2 | 45.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
123.5 | 118.2 | 117.8 | 120.1 | 107.8 | 132.7 | - | - | 62.5 | 117.3 | - | 148.1 | 115.4 | 116.9 | - | 153.8 | 143.4 | 99.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | 14.6 | - | - | 12.6 | 21.1 | - | 29.4 | 26.2 | 26.1 | - | 37.7 | 35.2 | 24.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
170.8 | 165.0 | 176.4 | 184.7 | 177.5 | 245.2 | - | - | 85.2 | 161.8 | - | 181.4 | 158.4 | 170.1 | - | 206.8 | 242.6 | 145.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
170.8 | 165.0 | 176.4 | 184.7 | 177.5 | 230.7 | - | - | 72.5 | 140.6 | - | 152.0 | 132.3 | 144.0 | - | 169.0 | 207.4 | 120.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency